Literature DB >> 31464068

Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer.

Lingmin Zhang1, Jingxin Chen2, Li Wang3, Lin Chen4, ZhaoZhao Du5, Lin Zhu5, Manli Cui5, Mingxin Zhang5, Liping Song6.   

Abstract

This manuscript aimed to investigate linc-PINT's role as a tumor suppressor and its downstream microRNAs (miRNAs) in esophageal cancer. Log-rank, Cox, and nomogram were used for survival analysis. Quantitative real-time polymerase chain reaction was used to evaluate the expression. Cell counting kit-8 was used for proliferation tests. As for in vivo experiments, low expression of linc-PINT was associated with better prognosis; besides, the nomogram indicated that linc-PINT, miR-543, and miR-576-5p served well in predicting the survival rate. As for the in vitro experiments, linc-PINT could directly regulate miR-543 and miR-576-5p to inhibit the proliferation of Eca-109 cell line. In conclusion, linc-PINT-miR-543/miR-576-5p pathway could predict the prognosis and provide novel therapeutic targets for esophageal cancer.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  esophageal cancer; linc-PINT; miR-543; miR-576-5p; nomogram

Year:  2019        PMID: 31464068     DOI: 10.1002/jcb.28699

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  13 in total

1.  LncRNA GATA6-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer via Repressing microRNA-543 to Up-Regulating RKIP.

Authors:  Zixuan Gong; Xiaoyu Chen; YueChao Zhang; Cheng Liu; Zhibing Wang; Xiaoyan Xu; Jun Zhu; Tongqing Xue
Journal:  Cancer Manag Res       Date:  2020-09-29       Impact factor: 3.989

2.  Prognostic nomograms and risk-stratifying systems for predicting survival in patients with resected pT2-4aN0M0 esophageal carcinoma.

Authors:  Xiao-Meng Dou; Na Zhang; Yan-Yan Fang; Bo-Han Zhang; Jie-Jing Liao; Jing-Sheng Cai; Jin-Bo Li
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 3.005

3.  LINC-PINT alleviates lung cancer progression via sponging miR-543 and inducing PTEN.

Authors:  Shu Wang; Wenyang Jiang; Xinghua Zhang; Zilong Lu; Qing Geng; Wei Wang; Nan Li; Xinyong Cai
Journal:  Cancer Med       Date:  2020-01-25       Impact factor: 4.452

4.  Long Noncoding RNA LINC-PINT Suppresses Cell Proliferation, Invasion, and EMT by Blocking Wnt/β-Catenin Signaling in Glioblastoma.

Authors:  Hanshuo Zhu; Zheng Chen; Lin Shen; Tianchi Tang; Min Yang; Xuesheng Zheng
Journal:  Front Pharmacol       Date:  2021-01-11       Impact factor: 5.810

5.  Long intergenic noncoding RNA smad7 (Linc-smad7) promotes the epithelial-mesenchymal transition of HCC by targeting the miR-125b/SIRT6 axis.

Authors:  Lili Han; Lijun Jia; Ying Zan
Journal:  Cancer Med       Date:  2020-10-10       Impact factor: 4.452

6.  miR‑576‑5p promotes epithelial‑to‑mesenchymal transition in colorectal cancer by targeting the Wnt5a‑mediated Wnt/β‑catenin signaling pathway.

Authors:  Jialin Luo; Luying Liu; Jinwen Shen; Ning Zhou; Yanru Feng; Na Zhang; Quanquan Sun; Yuan Zhu
Journal:  Mol Med Rep       Date:  2020-12-10       Impact factor: 2.952

7.  LINC00667 Promotes Progression of Esophageal Cancer Cells by Regulating miR-200b-3p/SLC2A3 Axis.

Authors:  Jindun Pan; Yunhong Zang
Journal:  Dig Dis Sci       Date:  2021-07-27       Impact factor: 3.487

8.  Complement sC5b-9 and CH50 increase the risk of cancer-related mortality in patients with non-small cell lung cancer.

Authors:  Jing Li; Zhijun Cao; Lijie Mi; Zhihua Xu; Xiangmei Wu
Journal:  J Cancer       Date:  2020-10-18       Impact factor: 4.207

Review 9.  miRNAs Involved in Esophageal Carcinogenesis and miRNA-Related Therapeutic Perspectives in Esophageal Carcinoma.

Authors:  Giovanni Zarrilli; Francesca Galuppini; Valentina Angerilli; Giada Munari; Marianna Sabbadin; Vanni Lazzarin; Lorenzo Nicolè; Rachele Biancotti; Matteo Fassan
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

10.  LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.

Authors:  Xianguang Yang; Susheng Miao; Xionghui Mao; Cheng Xiu; Ji Sun; Rong Pei; Shenshan Jia
Journal:  Pathol Oncol Res       Date:  2021-04-01       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.